Pharma major Sun Pharmaceutical Industries Ltd on Wednesday said it closed Q2FY24 with lower operational revenue and net profit as compared to Q2FY23.In a regulatory filing, the company said for the quarter ended 30.9.2023 it had booked a .
Sun Pharmaceutical Standalone Q2 Net Down To Rs 888 6 Cr menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Philogen Spa and Sun Pharmaceutical Industries Ltd on Monday announced positive results from the Phase III Pivotal study in patients with fully resectable locally advanced melanoma. The study.
The new drug application filing for deuruxolitinib with the USFDA is based on two pivotal Phase III trials, which included over 1,200 patients, across more than 135 clinical trial sites, the company said.
Sun Pharma files new drug application with USFDA for investigational medicine to treat alopecia businesstelegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstelegraph.co.uk Daily Mail and Mail on Sunday newspapers.